118 related articles for article (PubMed ID: 19906923)
1. Androgen stimulates transcription and replication of xenotropic murine leukemia virus-related virus.
Dong B; Silverman RH
J Virol; 2010 Feb; 84(3):1648-51. PubMed ID: 19906923
[TBL] [Abstract][Full Text] [Related]
2. Xenotropic murine leukemia virus-related virus establishes an efficient spreading infection and exhibits enhanced transcriptional activity in prostate carcinoma cells.
Rodriguez JJ; Goff SP
J Virol; 2010 Mar; 84(5):2556-62. PubMed ID: 20015990
[TBL] [Abstract][Full Text] [Related]
3. Androgen-independent proliferation of LNCaP prostate cancer cells infected by xenotropic murine leukemia virus-related virus.
Kakoki K; Kamiyama H; Izumida M; Yashima Y; Hayashi H; Yamamoto N; Matsuyama T; Igawa T; Sakai H; Kubo Y
Biochem Biophys Res Commun; 2014 Apr; 447(1):216-22. PubMed ID: 24721431
[TBL] [Abstract][Full Text] [Related]
4. Integration site preference of xenotropic murine leukemia virus-related virus, a new human retrovirus associated with prostate cancer.
Kim S; Kim N; Dong B; Boren D; Lee SA; Das Gupta J; Gaughan C; Klein EA; Lee C; Silverman RH; Chow SA
J Virol; 2008 Oct; 82(20):9964-77. PubMed ID: 18684813
[TBL] [Abstract][Full Text] [Related]
5. NF-kappaB activation stimulates transcription and replication of retrovirus XMRV in human B-lineage and prostate carcinoma cells.
Sakakibara S; Sakakibara K; Tosato G
J Virol; 2011 Apr; 85(7):3179-86. PubMed ID: 21270144
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of xenotropic murine leukemia virus-related virus (XMRV) to retroviral restriction factors.
Groom HC; Yap MW; Galão RP; Neil SJ; Bishop KN
Proc Natl Acad Sci U S A; 2010 Mar; 107(11):5166-71. PubMed ID: 20194752
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of xenotropic murine leukemia virus-related virus by APOBEC3 proteins and antiviral drugs.
Paprotka T; Venkatachari NJ; Chaipan C; Burdick R; Delviks-Frankenberry KA; Hu WS; Pathak VK
J Virol; 2010 Jun; 84(11):5719-29. PubMed ID: 20335265
[TBL] [Abstract][Full Text] [Related]
8. Fidelity of target site duplication and sequence preference during integration of xenotropic murine leukemia virus-related virus.
Kim S; Rusmevichientong A; Dong B; Remenyi R; Silverman RH; Chow SA
PLoS One; 2010 Apr; 5(4):e10255. PubMed ID: 20421928
[TBL] [Abstract][Full Text] [Related]
9. Human APOBEC3 proteins can inhibit xenotropic murine leukemia virus-related virus infectivity.
Bogerd HP; Zhang F; Bieniasz PD; Cullen BR
Virology; 2011 Feb; 410(1):234-9. PubMed ID: 21131013
[TBL] [Abstract][Full Text] [Related]
10. Characterization of retroviral and lentiviral vectors pseudotyped with xenotropic murine leukemia virus-related virus envelope glycoprotein.
Sakuma T; De Ravin SS; Tonne JM; Thatava T; Ohmine S; Takeuchi Y; Malech HL; Ikeda Y
Hum Gene Ther; 2010 Dec; 21(12):1665-73. PubMed ID: 20507233
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of cellular determinants required for in vitro xenotropic murine leukemia virus-related virus entry into human prostate cancer and noncancerous cells.
Bhosle S; Suppiah S; Molinaro R; Liang Y; Arnold R; Diehl W; Makarova N; Blackwell J; Petros J; Liotta D; Hunter E; Ly H
J Virol; 2010 Jul; 84(13):6288-96. PubMed ID: 20410264
[TBL] [Abstract][Full Text] [Related]
12. Lack of evidence for xenotropic murine leukemia virus-related virus(XMRV) in German prostate cancer patients.
Hohn O; Krause H; Barbarotto P; Niederstadt L; Beimforde N; Denner J; Miller K; Kurth R; Bannert N
Retrovirology; 2009 Oct; 6():92. PubMed ID: 19835577
[TBL] [Abstract][Full Text] [Related]
13. [Host factor Moloney leukemia virus 10 (MOV10) protein inhibits replication of the xenotropic murine leukemia virus-related virus (XMRV)].
Zhang Y; Hu SQ; Pang XJ; Li J; Guo F
Bing Du Xue Bao; 2014 Sep; 30(5):514-20. PubMed ID: 25562960
[TBL] [Abstract][Full Text] [Related]
14. Distribution of xenotropic murine leukemia virus-related virus (XMRV) infection in chronic fatigue syndrome and prostate cancer.
Mikovits JA; Huang Y; Pfost MA; Lombardi VC; Bertolette DC; Hagen KS; Ruscetti FW
AIDS Rev; 2010; 12(3):149-52. PubMed ID: 20842203
[TBL] [Abstract][Full Text] [Related]
15. The human retrovirus XMRV in prostate cancer and chronic fatigue syndrome.
Silverman RH; Nguyen C; Weight CJ; Klein EA
Nat Rev Urol; 2010 Jul; 7(7):392-402. PubMed ID: 20517289
[TBL] [Abstract][Full Text] [Related]
16. Evidence and controversies on the role of XMRV in prostate cancer and chronic fatigue syndrome.
Menéndez-Arias L
Rev Med Virol; 2011 Jan; 21(1):3-17. PubMed ID: 21294212
[TBL] [Abstract][Full Text] [Related]
17. Development of two androgen receptor assays using adenoviral transduction of MMTV-luc reporter and/or hAR for endocrine screening.
Hartig PC; Bobseine KL; Britt BH; Cardon MC; Lambright CR; Wilson VS; Gray LE
Toxicol Sci; 2002 Mar; 66(1):82-90. PubMed ID: 11861975
[TBL] [Abstract][Full Text] [Related]
18. Biochemical properties of the xenotropic murine leukemia virus-related virus integrase.
Mbemba G; Henry E; Delelis O; Bouger MC; Buckle M; Mouscadet JF; Hazan U; Leh H; Bury-Moné S
Biochimie; 2014 Dec; 107 Pt B():300-9. PubMed ID: 25260582
[TBL] [Abstract][Full Text] [Related]
19. Raltegravir is a potent inhibitor of XMRV, a virus implicated in prostate cancer and chronic fatigue syndrome.
Singh IR; Gorzynski JE; Drobysheva D; Bassit L; Schinazi RF
PLoS One; 2010 Apr; 5(4):e9948. PubMed ID: 20376347
[TBL] [Abstract][Full Text] [Related]
20. Fibrils of prostatic acid phosphatase fragments boost infections with XMRV (xenotropic murine leukemia virus-related virus), a human retrovirus associated with prostate cancer.
Hong S; Klein EA; Das Gupta J; Hanke K; Weight CJ; Nguyen C; Gaughan C; Kim KA; Bannert N; Kirchhoff F; Munch J; Silverman RH
J Virol; 2009 Jul; 83(14):6995-7003. PubMed ID: 19403677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
